Addendum: Newly diagnosed papillary craniopharyngioma with BRAF V600E mutation treated with single-agent selective BRAF inhibitor dabrafenib: a case report.
Oncotarget（2023）
关键词
papillary craniopharyngioma,selective braf inhibitor dabrafenib,braf v600e mutation,single-agent
AI 理解论文
溯源树
样例
生成溯源树，研究论文发展脉络
Chat Paper
正在生成论文摘要